WESPAC Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

WESPAC Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-23,709	Closed	-$1.28M	–	110
2015 Q4	$1.28M	Buy	+23,709	New	+$1.25M	1.48%	25
2015 Q3	–	Sell	-16,686	Closed	-$972K	–	87
2015 Q2	$972K	Sell	16,686 -2,406	-13%	-$141K	0.73%	54
2015 Q1	$1.1M	Sell	19,092 -384	-2%	-$21K	0.83%	49
2014 Q4	$983K	Sell	19,476 -1,623	-8%	-$79.1K	0.69%	55
2014 Q3	$987K	Buy	21,099 +6,879	+48%	+$310K	0.79%	50
2014 Q2	$640K	Sell	14,220 -7,047	-33%	-$303K	0.73%	57
2014 Q1	$898K	Sell	21,267 -360	-2%	-$15.1K	0.78%	53
2013 Q4	$851K	Buy	21,627 +3,330	+18%	+$125K	0.71%	60
2013 Q3	$649K	Buy	18,297 +6,375	+53%	+$224K	0.76%	53
2013 Q2	$396K	Buy	+11,922	New	+$396K	0.6%	65

Other funds holding IHE

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

Spinnaker Trust Portland, Maine $2.06B AUM 24.94% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

EAMA

EFG Asset Management (Americas) Miami, Florida $579M AUM 24.22% 1-Year Est. Return

WESPAC Advisors's IHE Position: Q1 2016 in Review

WESPAC Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2016, closing a stake of 23,709 shares — an estimated $1.28M sold.

WESPAC Advisors first reported a position in IHE in Q2 2013 and held it in 10 quarters. The position peaked at $1.28M in Q4 2015. 91 funds tracked by Wall St. Rank hold IHE as of Q1 2016.

WESPAC Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
WESPAC Advisors sold 23,709 iShares US Pharmaceuticals ETF shares in Q1 2016, an estimated $1.28M.
WESPAC Advisors first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 10 quarters.
WESPAC Advisors's iShares US Pharmaceuticals ETF position peaked at $1.28M in Q4 2015.
91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2016.

Based on WESPAC Advisors's 13F filing for Q1 2016, filed 25 Apr 2016.